Drug intelligence / Profile preview

Persumac

Development stage
Phase 2
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Persumac is an Iranian traditional herbal remedy composed of a powdered mixture of sumac (Rhus coriaria) and Bunium persicum (also known as black cumin or black zira). It has been studied for its potential anti-emetic effects, particularly in the management of chemotherapy-induced nausea and vomiting (CINV) in cancer patients. Clinical trials suggest that Persumac may reduce both the number and severity of nausea and vomiting episodes in patients with refractory CINV. The mechanism is not fully elucidated but is presumed to involve anti-inflammatory, antioxidant, or gastrointestinal-modulating properties attributed to its plant-based components[1][2][3][5].

Brand names
Persumac
Other names
sumac and Bunium persicum powdersumac/black cumin powderRhus coriaria and Bunium persicum Boiss. mixture

Beyond the preview

Go deeper on Persumac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Persumac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call